Brief Article
Copyright ©2010 Baishideng.
World J Gastroenterol. Jan 14, 2010; 16(2): 225-231
Published online Jan 14, 2010. doi: 10.3748/wjg.v16.i2.225
Table 2 Prevalence of HBV, HCV, and HEV serological markers, as well as HBV-DNA, in individual haemodialysis units n (%)
Unit 1 (n = 60)Unit 2 (n = 70)Unit 3 (n = 119)Unit 4 (n = 56)Unit 5 (n = 61)Total (n = 366)
HBsAg9 (15)2 (2.9)3 (2.5)2 (3.6)4 (6.6)20 (5.5)
Anti-HBs41 (68.3)39 (55.7)87 (73.1)38 (67.9)40 (65.6)245 (66.9)
Anti-HBc32 (53.3)40 (57.1)39 (32.8)35 (62.5)29 (47.5)175 (47.8)
HBeAg001 (0.8)1 (1.8)02 (0.5)
Anti-HBe13 (21.7)14 (20)15 (12.6)17 (30.4)14 (23)73 (19.9)
HBV-DNA6 (10)1 (1.4)3 (2.5)2 (3.6)3 (4.9)15 (4.1)
Anti-HCV7 (11.7)27 (38.6)27 (22.7)20 (35.7)7 (11.5)88 (24)
Anti-HEV3 (5)1 (1.4)4 (3.4)1 (1.8)6 (9.8)15 (4.1)